Segments - Acute Care Needleless Connectors Market by Type (Negative Fluid Displacement, Neutral Displacement, Positive Fluid Displacement, and Others), Application (Blood Collection, Infusion, Transfusion of Blood, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2024–2032
The global acute care needleless connectors market size was USD 2.17 Billion in 2023 and is projected to reach USD 5.51 Billion by 2032, expanding at a CAGR of 10.9% during 2024–2032. The market growth is attributed to the increasing awareness of infection control measures.
Increasing demand for safe and efficient medical devices leads to the growing adoption of acute care needleless connectors, further boosting the market. Acute care needleless connectors are used extensively in intravenous therapy, catheterization procedures, and blood transfusions. Moreover, the growing consumer base for acute care needleless connectors for infection prevention and patient safety initiatives drive the market.
The use of artificial intelligence is likely to boost the acute care needleless connectors market. AI-powered algorithms analyze vast amounts of patient data, clinical outcomes, and device performance metrics to identify patterns, trends, and insights that inform the development of next-generation needleless connectors with improved safety, efficacy, and user experience. Additionally, AI-driven predictive analytics enable manufacturers to anticipate purchaser trends, customer preferences, and regulatory requirements to develop strategic decision-making and product positioning in a competitive market environment.
Surging prevalence of chronic diseases globally is projected to drive the market during the forecast period. Chronic diseases such as diabetes, cancer, and cardiovascular disorders require long-term intravenous therapy and medication administration for disease management and symptom relief. This created a growing need for reliable and safe infusion delivery systems, including needleless connectors to facilitate seamless medication administration, while reducing the risk of catheter-related complications. Additionally, the aging population, coupled with lifestyle changes and environmental factors, contributes to the rising incidence of chronic diseases worldwide, which further fuels the demand for needleless connectors across healthcare settings.
Cost constraints and budgetary limitations among healthcare facilities are expected to hinder the market in the coming years. Healthcare settings in resource-constrained regions or developing economies are facing financial constraints that limit their ability to invest in expanding medical devices and technology, including acute care needleless connectors. Additionally, the lack of availability of cost-effective and long-term usable acute care needleless connectors further hamper the market.
Ongoing research and development activities are anticipated to create immense opportunities for the players competing in the market during the forecast period. Market players are focusing on innovating and introducing next-generation needleless connector technologies. Furthermore, the growing adoption of smart infusion systems and connected healthcare technologies such as RFID tracking, barcode scanning, and electronic documentation capabilities into needleless connector devices. These all factors are further boosting the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.
Attributes | Details |
Report Title | Acute Care Needleless Connectors Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year | 2023 |
Historic Data | 2017 -2022 |
Forecast Period | 2024–2032 |
Segmentation | Type (Negative Fluid Displacement, Neutral Displacement, Positive Fluid Displacement, and Others), and Application (Blood Collection, Infusion, Transfusion of Blood, and Others) |
Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report | B. Braun SE; Baihe Medical Technology Co.Ltd; Baxter ; BD; Cardinal Health; CareFusion Corporation; ICU Medical Inc.; Nexus Medical; RyMed Technologies, LLC; and Vygon SA |
Based on type, the acute care needleless connectors market is divided into negative fluid displacement, neutral displacement, positive fluid displacement, and others. The negative fluid displacement segment held the major share of the market in 2023, due to the widespread adoption of negative fluid displacement connectors in the healthcare setting. These connectors have the ability to prevent backflow and air embolisms during intravenous therapy and catheterization procedures. Moreover, the versatility and compatibility of negative fluid displacement connectors with various medical devices and infusion systems further boost the segment.
The positive fluid displacement segment is expected to expand at a significant growth rate in the coming years, owing to the increasing recognition of the benefits of positive fluid displacement. These connectors help in preventing catheter-related bloodstream infections (CRBSIs). Furthermore, technological advancements in positive fluid displacement connector design, such as integrated antimicrobial coatings and needle-free injection ports, further drive the segment.
On the basis of application, the global market is segregated into blood collection, infusion, transfusion of blood, and others. The transfusion of blood segment is expected to register a high market revenue during the projection period, owing to the growing demand for blood transfusions in surgical procedures, trauma care, and treatment of hematological disorders. Furthermore, governmental regulatory initiatives focus on improving transfusion safety standards while reducing the risk of transfusion-transmitted infections, thereby increasing utilization of needleless connectors.
In terms of region, the global acute care needleless connectors market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to the presence of strong and well-established healthcare infrastructure. Moreover, healthcare providers in the region prioritize patient safety and quality of care, further propelling the widespread adoption of needleless connectors to minimize the risk of healthcare-associated infections (HAIs) and improve clinical outcomes. These all factors are contributing to fueling the North America market during the forecast period.
The market in Asia Pacific is projected to expand at a significant pace in the coming years, owing to rapidly expanding healthcare infrastructure and rising awareness regarding infection control measures. Additionally, the growing prevalence of chronic diseases and the presence of an aging population further create the need for effective infection prevention strategies, thereby boosting the demand for needleless connectors.
As per the report published by the United States Census Bureau on June 21, 2022, Eastern Asia is projected to have a population where 33.7% are aged 65 and older by 2060.
The acute care needleless connectors market has been segmented on the basis of
Key players competing in the global acute care needleless connectors market are B. Braun SE; Baihe Medical Technology Co.Ltd; Baxter ; BD; Cardinal Health; CareFusion Corporation; ICU Medical Inc.; Nexus Medical; RyMed Technologies, LLC; and Vygon SA.
These companies use development strategies including mergers, acquisitions, partnerships, collaboration, and product launches to expand their consumer base globally.
On December 14, 2023, B. Braun Medical Inc, a major company in medical innovation, announced the release of CARESITE Micro luer access device. This technology is the only needleless connector that does not contain Bisphenol A (BPA), which is a harmful chemical that causes multi-organ toxicity. Moreover, the CARESITE microdevice has the potential to decrease the chances of infections and drug exposure resulting from stress cracks caused by the incompatibility of material and drugs.